news 2011

Researchers from Novartis have reported new dual-acting class of antimalarial compounds with potential to both prevent and treat malaria infections. A new class of antimalarial drug candidates inhibits malaria parasite liver-and blood-stages in malaria models. Most current malaria treatments target blood infections but researchers believe both liver and blood infections need to be treated to eliminate malaria.

Newly discovered mechanisms lay the foundation for a new therapeutic avenues that one day may be beneficial in treating diseases, ranging from muscle weakness and frailty to obesity and diabetes. Researchers from EPFL published a study which highlight on the roles of a nuclear receptor co-repressor, NCoR1.

Like far away galaxies, powerful tools are required to bring the minute inner workings of neurons into focus. A team of scientists report how Digital Holographic Microscopy (DHM) can now be used to observe neuronal activity in real-time and in three dimensions—with up to 50 times greater resolution than ever before.

Detecting cancer cells and destroying them, injecting drugs with extreme precision into diseased cells in the human body - these are just two examples of what scientists are attempting to accomplish using iron oxide nanoparticles.

If you regularly take pain killers - even those available over the counter - you often expose yourself to higher risks of heart attack and apoplexy.